223 related articles for article (PubMed ID: 6136102)
41. Criticism of prophylaxis of gastrointestinal bleeding with H2 receptor antagonists is wrong.
Cook TM
BMJ; 1997 Aug; 315(7104):371-2. PubMed ID: 9270476
[No Abstract] [Full Text] [Related]
42. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2).
Feldman M; Burton ME
N Engl J Med; 1990 Dec; 323(25):1749-55. PubMed ID: 1978926
[No Abstract] [Full Text] [Related]
43. [Action of histamine H2 receptor blockaders on gastric motor function in duodenal peptic ulcer].
Shcherbak VV; Glubochenko VG; Zaĭdman VE
Klin Med (Mosk); 1984 Jun; 62(6):94-6. PubMed ID: 6147438
[No Abstract] [Full Text] [Related]
44. Histamine H2 antagonists in acute upper gastrointestinal hemorrhage.
Dahan R; Caulin C
N Engl J Med; 1986 Mar; 314(11):716-7. PubMed ID: 2869407
[No Abstract] [Full Text] [Related]
45. [Histamine H2 receptor antagonists in gastroduodenal pathology].
Puşcaş I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):299-304. PubMed ID: 30144
[No Abstract] [Full Text] [Related]
46. H2-receptor antagonists.
Ivey KJ
Int J Dermatol; 1980 May; 19(4):175-81. PubMed ID: 6105135
[No Abstract] [Full Text] [Related]
47. Satellite symposium: New therapeutic approach to peptic ulcer disease. 34th annual meeting of the Japanese Society of Gastroenterology.
Gastroenterol Jpn; 1993 May; 28 Suppl 5():191-201. PubMed ID: 8103024
[No Abstract] [Full Text] [Related]
48. Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
Bank S
Med J Aust; 1985 Feb; 142(3):S17-20. PubMed ID: 2857473
[No Abstract] [Full Text] [Related]
49. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
Schulman MI; Orlando RC
Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649
[No Abstract] [Full Text] [Related]
50. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
Malfertheiner P; Fass R; Quigley EM; Modlin IM; Malagelada JR; Moss SF; Holtmann G; Goh KL; Katelaris P; Stanghellini V; Talley NJ; Tytgat GN; Wright NA
Aliment Pharmacol Ther; 2006 Mar; 23(6):683-90. PubMed ID: 16556170
[TBL] [Abstract][Full Text] [Related]
51. [A common disease: heartburn. Self-medication with low-dose H2-receptor antagonists].
Internist (Berl); 1998 Nov; 39(11 Suppl Selbstmedi):1-4. PubMed ID: 9844840
[No Abstract] [Full Text] [Related]
52. [Ulcer surgery during 1976-1978 and 1986-1988. Significance of H2 blockaders in surgical training].
Meisner S; Sørensen A; Wille-Jørgensen PA
Ugeskr Laeger; 1993 Nov; 155(47):3828-32. PubMed ID: 7903009
[TBL] [Abstract][Full Text] [Related]
53. Eradication treatment for Helicobacter pylori in general practice.
Fraser AG; Moore L; Berry S; Arroll B
N Z Med J; 1996 Nov; 109(1033):422-4. PubMed ID: 8941293
[TBL] [Abstract][Full Text] [Related]
54. [German language reprints of original papers from the supplement "Nizatidine in peptic ulcer disease" of the Scandinavian Journal of Gastroenterology, Volume 22, Supplement 136, 1987].
Fortschr Med; 1989 Jan; Spec No 1():1-48. PubMed ID: 2563715
[No Abstract] [Full Text] [Related]
55. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
Marcus P; McCauley DL
Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
[No Abstract] [Full Text] [Related]
56. [H2 blockers and acute peptic ulcer].
Müller P; Dammann HG; Simon B
Fortschr Med; 1986 Dec; 104(3):903-7. PubMed ID: 2881861
[No Abstract] [Full Text] [Related]
57. Intragastric pH and control of peptic ulcer bleeding.
Arora A; Tandon RK; Acharya SK
Am J Gastroenterol; 1991 Jan; 86(1):116-7. PubMed ID: 1670904
[No Abstract] [Full Text] [Related]
58. [Experience in clinical use of quamatel in upper gastrointestinal hemorrhage].
Shlevkov BA; Abramova LA; Toguzova DA
Khirurgiia (Mosk); 2001; (7):45-8. PubMed ID: 11521310
[No Abstract] [Full Text] [Related]
59. Pharmacologic strategies for treating gastroesophageal reflux disease.
Vivian EM; Thompson MA
Clin Ther; 2000 Jun; 22(6):654-72. PubMed ID: 10929915
[TBL] [Abstract][Full Text] [Related]
60. [What is the role of H2 receptor blockers today in ulcer therapy?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
